Heterocyclic Compounds from Marine Organisms 2.0

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 4096

Special Issue Editor


E-Mail Website
Guest Editor
Department of Organic Chemistry, Faculty of Science, University of Valladolid, Campus Miguel Delibes, 47011 Valladolid, Spain
Interests: heterocyclic chemistry; organosilanes; natural products synthesis; multicomponent reactions
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Marine natural products have played an important role in the development of new bioactive compounds with a variety of interesting properties (antiviral, cytotoxic, antitumor, anti-inflammatory, antimicrobial, and others). Within the molecules produced by these marine organisms, the presence of heterocyclic sub-units is quite frequent. The structural diversity of this group of marine compounds, together with their diverse biological activities, has attracted the attention of the scientific community. Following the success of the Special Issue “Heterocyclic Compounds from Marine Organisms, https://www.mdpi.com/journal/marinedrugs/special_issues/Heterocyclic_Marine”, we are delighted to edit the second Special Issue on this topical area. This Special Issue on "Heterocyclic Compounds from Marine Organisms 2.0" aims to provide an overview of the most recent developments related to the isolation, characterization, synthesis, or biosynthesis of marine compounds containing heterocyclic units or structural-related analogs.

As Guest Editor, I cordially invite contributions in the form of original research articles or reviews from this exciting research field.

Prof. Dr. Asunción Barbero
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • heterocycles
  • synthesis
  • biosynthesis
  • marine drugs
  • analogs

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

23 pages, 6346 KiB  
Review
Recent Advances in Biologically Active Coumarins from Marine Sources: Synthesis and Evaluation
by Laura Fernández-Peña, Maria João Matos and Enol López
Mar. Drugs 2023, 21(1), 37; https://doi.org/10.3390/md21010037 - 31 Dec 2022
Cited by 14 | Viewed by 3615
Abstract
Coumarin and its derivatives have significantly attracted the attention of medicinal chemists and chemical biologists due to their huge range of biological, and in particular, pharmacological properties. Interesting families of coumarins have been found from marine sources, which has accelerated the drug discovery [...] Read more.
Coumarin and its derivatives have significantly attracted the attention of medicinal chemists and chemical biologists due to their huge range of biological, and in particular, pharmacological properties. Interesting families of coumarins have been found from marine sources, which has accelerated the drug discovery process by inspiring innovation or even by the identification of analogues with remarkable biological properties. The purpose of this review is to showcase the most interesting marine-derived coumarins from a medicinal chemistry point of view, as well as the novel and useful synthetic routes described to date to achieve these chemical structures. The references that compose this overview were collected from PubMed, Mendeley and SciFinder. Full article
(This article belongs to the Special Issue Heterocyclic Compounds from Marine Organisms 2.0)
Show Figures

Graphical abstract

Back to TopTop